Pharmaceutical Technology

SEPTEMBER 15, 2022

Contract marketing companies offer various marketing services that connect suitable strategies with customers at different points in the product lifecycle, helping to increase the customer base and thus revenue. Finding the top API chemical companies in contract marketing.

Marketing 130

Marketing Manufacturing Generic Drugs Containment 130

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Find the leading clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

FDA Law Blog

SEPTEMBER 26, 2023

(HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.

Marketing 59

Marketing Life Science Compliance Business Development 59

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. Discover the top commercial dose injectables companies in contract marketing.

Marketing 130

Marketing Containment Production Sales 130

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

Pharmaceutical Technology

SEPTEMBER 14, 2022

More than 100 approved peptide-based therapeutics are currently available in the market. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services. Discover the top API protein and peptide companies in contract marketing.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Discover the top pharmaceutical compounding companies in contract marketing. Test method development. . Test method development.

Marketing 130

Marketing Pharmacy Containment Sales 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Drug Discovery World

APRIL 18, 2023

Sascha Fischer, Business Development Manager for Automation at Genedata looks at three critical digitalisation components that streamline the journey to market. Username or E-mail Password Remember Me Forgot Password The post Accelerating time to market through digitalisation appeared first on Drug Discovery World (DDW).

Marketing 52

Marketing Business Development Drugs Development 52

pharmaphorum

AUGUST 8, 2022

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 110

Marketing Sales Gene Editing Antibody 110

Pharmaceutical Technology

MAY 29, 2023

FivepHusion has collaborated with Treehill Partners and Syneos Health to strategically progress development and commercialisation of its chemotherapeutic formulation Deflexifol in markets across the globe. Syneos will support the commercialisation and clinical development capabilities of FivepHusion.

Business Development 130

Business Development Development Marketing Clinical Development 130

BioSpace

JUNE 29, 2022

billion to expand Blueprint's pipeline and pursue business development opportunities. Blueprint Medicines announced strategic financing collaborations with Sixth Street and Royalty Pharma for up to $1.25

Marketing 72

Marketing Business Development Medicine Development 72

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 102

Genome Genomics Medicine Development 102

BioPharma Reporter

MARCH 14, 2022

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Business Development 105

BioPharma Reporter

MAY 15, 2024

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing.

Manufacturing 52

Manufacturing Contract Manufacturing Gene Therapy Business Development 52

XTalks

JANUARY 17, 2024

Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.

Life Science 115

Life Science Engineer Business Development Manufacturing 115

pharmaphorum

JANUARY 28, 2021

It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. million patients.

Marketing 102

Marketing Insulin HR Production 102

BioPharma Reporter

NOVEMBER 21, 2023

OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.

Branding 93

Branding Business Development Sales Development 93

Drug Discovery World

OCTOBER 26, 2022

Optibrium, a software and artificial intelligence (AI) solutions developer for drug discovery, has announced three appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager. .

Drugs 52

Drugs Business Development Life Science Marketing 52

BioSpace

JULY 4, 2022

BioSpace spoke with the company's head of product portfolio strategy and business development, Yannis Morel, Ph.D. Many of Innate Pharma’s cancer-fighting products are making clinical progress.

Marketing 40

Marketing Business Development Production Research 40

Pharmaceutical Technology

FEBRUARY 1, 2023

We believe that the combination of these expected near-term launches, additional pipeline products that could potentially come to market in the medium-term, and anticipated contributions from business development, has the potential to set the company up for continued robust growth through the rest of this decade and beyond.”

Business Development 261

Business Development Production Marketing Development 261

pharmaphorum

OCTOBER 1, 2021

It has made Oxford Nanopore’s chief executive and cofounder Gordon Sanghera an on-paper fortune of £63 million, while another cofounder – chief business development officer Spike Willcocks – is now worth £30 million. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

Marketing 52

Marketing Business Development Genome Genomics 52

Pharmaceutical Technology

MAY 5, 2023

Hasten also purchased Rocephin’s marketing authorisation and intellectual property including trademarks. This investment helped the firm to support the business development of its pipeline assets. Hasten Biopharmaceutic has purchased the commercial rights for Rocephin in mainland China from Swiss healthcare firm Roche.

Business Development 130

Business Development Marketing Development 130

pharmaphorum

AUGUST 4, 2020

to develop an intra-uterine sensor system and generate clinical data that could be used for European approval. If the data support European approval, the sensor would be the company’s first product on the market. ” The post VivoPlex raises funding to develop intra-uterine sensor appeared first on. .

Development 52

Development Production Pharma Companies Engineer 52

Pharmaceutical Technology

JULY 1, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. The company noted that the deal will bring substantial non-dilutive, low-cost capital to boost innovation and growth.

Medicine 147

Medicine Business Development Sales Life Science 147

pharmaphorum

OCTOBER 12, 2022

One of the biggest challenges when it comes to KOL identification and mapping is that of addressing high-growth markets and specific geographies. The example we often use from our own experience is of Multiple Sclerosis in one of the world’s largest emerging markets. Business Development Account Manager. Robert Hollands.

Marketing 52

Marketing Containment Business Development Research 52

Drug Channels

MARCH 10, 2023

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers.

Pharmacy 79

Pharmacy Business Development Drugs Marketing 79

Camargo

SEPTEMBER 23, 2020

Thomas Kassberg, Chief Business Officer, Ultragenyx. Thomas Kassberg, Chief Business Officer, Ultragenyx. I think you really need to get the feedback directly from patients and then incorporate that feedback as you think about how you’re going to develop the product to be successful. Marketing Manager. Dan Curran, Takeda.

Business Development 136

Business Development Drugs Development Production 136

Pharmaceutical Technology

SEPTEMBER 6, 2022

The growing need for better pharmaceutical logistics, the rising demand for fast-track support, as well as growing adoption of telematics in pharmaceutical logistics are some of the important factors that are expected to drive the pharmaceutical logistics market. Finding the top pharmaceutical logistics and pharma supply chain companies.

Containment 147

Containment Pharmacy Life Science Production 147

Intouch Solutions

NOVEMBER 16, 2021

Breithaupt has been integral in building the media services department — hiring talent, developing media resources, and growing Intouch’s client roster, as well as evolving media capabilities and applying a pharma lens to her work. Collectively, Intouch Group employs more than 1,400 people.

Development 52

Development Life Science Packaging Packaging 52

Pharmaceutical Technology

SEPTEMBER 7, 2022

The growing prevalence of chronic diseases and rising geriatric population has led to increasing demand for advanced medication adherence systems, personalised healthcare, and mobile health systems, which are the major driving factors for the patient adherence market. Discover the leading patient adherence pharmaceutical companies.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

Drugs 147

Drugs Medicine Marketing Development 147

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesale pharmaceutical companies also offer services such as end formulation contracts, which help pharmaceutical marketing companies and pharmacies locate manufacturing units across regions and coordinate negotiations when required. Discover the top pharmaceutical wholesalers. Geographical location for timely delivery.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

Drug Channels

MARCH 11, 2022

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey analyzes trends in patient support services and reimbursement hubs. Click here to schedule your meeting.

Pharmacy 74

Pharmacy Business Development Marketing Drugs 74

Drug Discovery World

NOVEMBER 21, 2023

The new business will be looking for high-quality, mid- to late-stage assets, clinically focused on the US market. Companies who design their development plans to address multifaceted needs, beyond regulatory requirements, are the ones most likely to succeed,” said Pashazadeh.

Development 52

Development Clinical Development Production Business Development 52

Pharmaceutical Technology

MARCH 10, 2023

The pharmaceutical freeze-drying systems market is expected to be driven by the integration of smarter technologies in lyophilisation methods such as electron microscopy, biochemistry, and advancement in surgeries.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Drug Discovery World

SEPTEMBER 5, 2023

Stevens has moved from Director of Drug Discovery, where he had been driving Metrion’s scientific strategy to develop new assays. In her new role, Seth will leverage more than two decades of experience in translational research, pharmaceutical development, manufacturing, and program management.

Drugs 59

Drugs Business Development Life Science Development 59